IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lunate Capital Ltd

Q1 2026 Holdings

Filed 2026-04-16 | 6 holdings | $120.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$53.4M549,05044.4%
Sailpoint Inc(SAIL)COM78781J109$39.7M3,000,00033.0%
Lineage Inc(LINE)COM53566V106$19.7M600,00016.3%
Neumora Therapeutics Inc.(NMRA)COM640979100$4.1M2,124,1433.4%
Navan Inc(NAVN)CL A639193101$2.6M200,0002.2%
Revolution Medicines Inc(RVMDW)*W EXP 12/17/20276155X118$805.5K450,0000.7%